2026-09-302026-09-30https://scholars.csmu.edu.tw/handle/123456789/19549Docetaxel (TaxotereR) has emerged as a prime chemotherapeutic agent in adjuvant chemotherapy worldwide. However, the most common adverse effect of Docetaxel is myelosuppression, include neutropeni...(詳)歐洲紫杉醇 (商品名：Taxotere®)為世界常用的輔助化療之化療藥劑，然而Docetaxel會造成骨髓抑制的不良影響，包括：嗜中性白血球低下症和貧血。真菌免疫調節蛋白FIP-fve與FIP...(詳)靈芝免疫調節蛋白嗜中性白血球低下症顆粒性白血球群落刺激因子(G-CSF)骨損傷Ganoderma immunomodulatory proteinNeutropeniaGranulocyte colony-stimulating factor (G-CSF)Bone damageProject